Arovella Therapeutics Limited (AU:ALA) has released an update.
Arovella Therapeutics Limited has announced the application for quotation of 125 million ordinary fully paid securities under the ASX code ALA, with an issue date of April 4, 2024. This move, indicative of the company’s growth and investor interest, was formally submitted in line with ASX Listing Rules as per the latest announcement.
For further insights into AU:ALA stock, check out TipRanks’ Stock Analysis page.
